Ruxolitinib Cream 1.5% Significantly Improves Chronic Hand Dermatitis at 4 Weeks
Interim analysis suggest the JAK inhibitor may become a breakthrough treatment for chronic hand dermatitis—a condition currently without a marketed drug.
United States Linkedin Hannah Smith Hannahd Smith University Of Rochester Medical Center Department Rochester Department Drug Administration
Source: hcplive.com